1. Home
  2. TPCS vs NSRX Comparison

TPCS vs NSRX Comparison

Compare TPCS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

HOLD

Current Price

$4.58

Market Cap

39.4M

Sector

Industrials

ML Signal

HOLD

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.06

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
NSRX
Founded
1956
2019
Country
United States
Israel
Employees
N/A
7
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
38.9M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TPCS
NSRX
Price
$4.58
$3.06
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
52.9K
11.6K
Earning Date
02-17-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
41.38
N/A
EPS
N/A
N/A
Revenue
$31,644,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$1.98
52 Week High
$6.25
$9.99

Technical Indicators

Market Signals
Indicator
TPCS
NSRX
Relative Strength Index (RSI) 51.16 48.82
Support Level $4.41 $2.78
Resistance Level $4.71 $3.60
Average True Range (ATR) 0.18 0.18
MACD -0.06 -0.01
Stochastic Oscillator 18.97 43.70

Price Performance

Historical Comparison
TPCS
NSRX

About TPCS TechPrecision Corporation

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: